Vol.44, No.2, 2020, pp.127-135, doi:10.32604/biocell.2020.010018
OPEN ACCESS
REVIEW
Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving
  • WENJUAN LI*, GE SONG
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA
* Address correspondence to: Wenjuan Li, wenjuan@scripps.edu
Received 04 February 2020; Accepted 08 April 2020; Issue published 27 May 2020
Abstract
From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this review for a brief summary.
Keywords
SARS-CoV2, Cellular mechanism, Therapies, Antibody, Vaccine
Cite This Article
LI, W., SONG, G. (2020). Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving. BIOCELL, 44(2), 127–135.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.